Related by context. Frequent words. (Click for all words.) 55 Shigamabs ® 54 atacicept 54 outlicensing 53 novel antibody therapeutics 53 SARMs 52 methylnaltrexone 52 elotuzumab 51 ATL# [001] 51 AZX# 50 OXi# 50 anticancer compounds 50 cancer immunotherapies 50 ASONEP 49 GSK# [001] 49 Phase IIa clinical trials 49 RiVax ™ 49 iSONEP 48 BioInvent 48 DDP# 48 dirucotide 48 regadenoson 48 squalamine 48 NKTR 48 NCEs 48 Epson disclaims 48 isavuconazole 48 Traficet EN 48 phage display 48 celgosivir 48 OncoMed 47 Virulizin R 47 daclizumab 47 Novexel 47 Fibrillex TM 47 NovaBay 47 PCK# 47 Urocidin 47 JAK3 46 phase IIb clinical 46 deforolimus 46 GLPG# 46 PEG SN# 46 HUYA 46 PsychoGenics 46 antiviral compounds 46 Inotek 46 alagebrium 46 Captisol 46 AVN# [001] 46 Ambrx 45 ALKS 45 Nol pros 45 forodesine 45 IMC A# 45 Cethrin 45 Astex 45 Diamyd ® 45 Phase Ib clinical 45 Janssen Pharmaceutica NV 45 PROMACTA 45 BioWa 45 romidepsin 45 BNC# 45 peptide therapeutics 44 ISTODAX 44 via sublicense 44 downregulation 44 registrational 44 goserelin 44 Oxford Nanopore 44 OMJPI 44 multiple myeloma MM 44 Rosetta dependence 44 SAR# [004] 44 ponatinib 43 Advinus 43 Lycera 43 ARM INC. 43 Bicifadine 43 BioSeek 43 Loramyc ® 43 NV Organon 43 Rotarix R 43 tanespimycin 43 advanced carcinoid 43 StemEx 43 Nasulin 43 genomics proteomics 43 rhC1INH 43 EOquin 43 eniluracil 43 Phase 2a trial 42 tiered royalties 42 AnGes 42 carbon nanomaterials 42 Mundipharma 42 Phase Ib 42 phase IIb 42 interferon beta 1b 42 pediatric exclusivity 42 Trizytek